Lataa...
A148 EBV STATUS AND IMMUNOSUPPRESSANT USE IN IBD PATIENTS WHO SUBSEQUENTLY DEVELOP LYMPHOMA: A RETROSPECTIVE AND PROSPECTIVE STUDY
BACKGROUND: Immunosuppressive agents have revolutionized the treatment of inflammatory bowel disease (IBD). However, a number of studies over the last decade have identified a concerning link between immunosuppression and lymphoproliferative disorders (LPDs). These LPDs have been associated with Eps...
Tallennettuna:
| Julkaisussa: | J Can Assoc Gastroenterol |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6508111/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy009.148 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|